Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-01-07 Sale | 2026-01-09 4:51 pm | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 25,156 | $40.2 | $1,011,299 | 312,407 (Direct) | View |
| 2026-01-02 Sale | 2026-01-06 4:31 pm | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 4,844 | $40.39 | $195,668 | 675,538 (Direct) | View |
| 2025-12-29 Sale | 2025-12-31 4:22 pm | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 45,000 | $40.56 | $1,825,355 | 342,407 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-01-07 Exercise | 2026-01-09 4:51 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 25,156 | $10.42 | 312,407 (Direct) | View |
| 2026-01-07 Exercise | 2026-01-09 4:51 pm | N/A 2032-10-26 | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 25,156 | $0 | 312,407 (Direct) | View |
| 2026-01-02 Exercise | 2026-01-06 4:31 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 4,844 | $10.42 | 675,538 (Direct) | View |
| 2026-01-02 Exercise | 2026-01-06 4:31 pm | N/A 2032-10-26 | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 4,844 | $0 | 675,538 (Direct) | View |
| 2025-12-29 Exercise | 2025-12-31 4:22 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 45,000 | $10.42 | 342,407 (Direct) | View |
| 2025-12-29 Exercise | 2025-12-31 4:22 pm | N/A 2032-10-26 | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 45,000 | $0 | 342,407 (Direct) | View |
| 2025-09-22 Option Award | 2025-09-24 4:24 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 40,000 | $0 | 40,000 (Direct) | View |
Ownership | 2025-01-30 4:22 pm | N/A 2032-10-26 | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 0 | $0 | 555,438 (Direct) | View |